TherapeuticsMD (TXMD) Non-cash Items (2011 - 2026)

TherapeuticsMD has reported Non-cash Items for 16 years, with the latest figure at $105000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 101.92% year-over-year to $105000.0; the trailing twelve-month figure through Mar 2026 stood at $105000.0 (up 101.92% YoY), and the FY2025 full-year result was $28000.0, down 50.88% from the prior year.
• Non-cash Items for Q1 2026 stood at $105000.0, down from $987000.0 in the prior quarter.
• The five-year high for Non-cash Items was $987000.0 in Q4 2025, with the low at -$18.2 million in Q4 2022.
• Historically, Non-cash Items has averaged -$1.8 million across 5 years, with a median of $51000.0 in 2025.
• Annual changes were most pronounced in 2023 — Non-cash Items plunged 213133.33% — and 2025, when it jumped 1117.53%.
• TherapeuticsMD's Non-cash Items stood at -$18.2 million in 2022, then jumped by 81.23% to -$3.4 million in 2023, then surged by 97.16% to -$97000.0 in 2024, then jumped by 1117.53% to $987000.0 in 2025, then slumped by 89.36% to $105000.0 in 2026.
• The last three Non-cash Items figures came in at $105000.0 (Q1 2026), $987000.0 (Q4 2025), and $51000.0 (Q3 2025), per Business Quant data.